TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$55.15
+1.01 (+1.87%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+39.13%
1Y
+280.61%
YTD
+39.55%
Open$54.66
Previous Close$54.14
Day High$55.99
Day Low$53.75
52W High$55.99
52W Low$13.88
Volume—
Avg Volume2.63M
Market Cap5.13B
P/E Ratio—
EPS$-0.27
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.84
Above
SMA 200
$24.79
Above
RSI (14)
40.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-32.6% upside
Current
$55.15
$55.15
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 511.53M | 386.70M | 873.79M |
| Net Income | -26,633,167 | -18,120,539 | 83.63M |
| Profit Margin | -5.2% | -5.0% | 9.6% |
| EBITDA | -3,766,212 | -2,704,793 | 111.75M |
| Free Cash Flow | — | — | 68.75M |
| Rev Growth | +32.3% | +32.3% | +12.5% |
| Debt/Equity | 2.71 | 2.71 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |